Literature DB >> 2761601

Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure.

J N Allen1, E R Pacht, J E Gadek, W B Davis.   

Abstract

Although chronic eosinophilic pneumonia is a well-known disorder, acute eosinophilic pneumonia has not been as well characterized. We describe the clinical features, results of bronchoalveolar lavage, and follow-up studies of four patients with acute eosinophilic pneumonia. The patients presented with an acute febrile illness, severe hypoxemia (partial pressure of arterial oxygen less than 60 mm Hg), diffuse pulmonary infiltrates, an increased number of eosinophils (mean +/- SEM, 42 +/- 4.8 percent) in bronchoalveolar-lavage fluid, and an absence of infection and previous atopic illness. The illness resolved rapidly after treatment with erythromycin and corticosteroids. The patients received doses of oral prednisone that were tapered over 10 days to 12 weeks, and none have relapsed since the steroids were discontinued. After a minimum follow-up period of five months, clinical evaluation, chest radiography, and pulmonary-function tests have shown no residual abnormalities attributable to the acute eosinophilic pneumonia. Follow-up bronchoalveolar lavage has demonstrated less than or equal to 1 percent eosinophils in all patients. We believe that we are describing an acute form of eosinophilic lung disease distinct from previously described syndromes. It can be diagnosed by bronchoalveolar lavage and seems to respond to treatment with corticosteroids.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2761601     DOI: 10.1056/NEJM198908313210903

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  44 in total

1.  Bloodless extracorporeal membrane oxygenation in the Jehovah's Witness patient.

Authors:  Thomas J Preston; Vincent F Olshove; Margaret Chase
Journal:  J Extra Corpor Technol       Date:  2012-03

2.  Pediatric Acute Respiratory Distress Syndrome and Hypersensitivity Pneumonitis Related to E-cigarette Vaping.

Authors:  Binh Phung; Anh Lam
Journal:  J Pediatr Intensive Care       Date:  2019-11-28

3.  Acute eosinophilic pneumonia with eosinophilic leukemoid reaction: a rare hematologic presentation.

Authors:  Sourya Acharya; Samarth Shukla; Pradyumna Gadewar; Manoj Gupta; S N Mahajan
Journal:  Indian J Hematol Blood Transfus       Date:  2013-05-15       Impact factor: 0.900

Review 4.  Evaluation and differential diagnosis of marked, persistent eosinophilia.

Authors:  Rojelio Mejia; Thomas B Nutman
Journal:  Semin Hematol       Date:  2012-04       Impact factor: 3.851

5.  Clinical outcomes in patients with acute eosinophilic pneumonia not treated with corticosteroids.

Authors:  Byung Woo Jhun; Se Jin Kim; Rak Chae Son; Hongseok Yoo; Byeong-Ho Jeong; Man Pyo Chung; Kyeongman Jeon
Journal:  Lung       Date:  2015-03-28       Impact factor: 2.584

Review 6.  Tobacco Worker's Lung: A Neglected Subtype of Hypersensitivity Pneumonitis.

Authors:  Vincenzo Zagà; Marco Dell'Omo; Nicola Murgia; Marco Mura
Journal:  Lung       Date:  2021-01-11       Impact factor: 2.584

Review 7.  Rapid diagnosis of acute eosinophilic pneumonia (AEP) in a patient with respiratory failure using bronchoalveolar lavage (BAL) with calcofluor white (CW) staining.

Authors:  T F Hogan; R S Riley; J G Thomas
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

Review 8.  Eosinophilic pneumonias.

Authors:  Praveen Akuthota; Peter F Weller
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

9.  Smoking-Induced Acute Eosinophilic Pneumonia in a 15-year-old Girl: A Case Report.

Authors:  Ji-Seok Youn; Ji-Won Kwon; Byoung-Ju Kim; Soo-Jong Hong
Journal:  Allergy Asthma Immunol Res       Date:  2010-03-24       Impact factor: 5.764

10.  Soluble CD26 is inversely Associated with Disease Severity in Patients with Chronic Eosinophilic Pneumonia.

Authors:  Osamu Matsuno; Eishi Miyazaki; Shinichi Nureki; Takuya Ueno; Masaru Ando; Toshihide Kumamoto
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.